In North America, the Metoclopramide HCL Prices showcased a marginal increase in the domestic market during the second quarter of 2022, backed by surging upstream benzoic acid costs. The demand from downstream pharmaceutical sectors was firm. Besides, the prices of upstream benzoic acid were inclining, which further propelled the metoclopramide hydrochloride prices in the upward direction. Logistic charges further added to the already augmenting price value of Benzoic acid, followed by increased costs of downstream API prices. In addition, the continued port congestions also prompted strong market sentiments for Metoclopramide hydrochloride. Towards the termination of Q2 2022, the value accessed was USD 135270/MT with a quarterly inclination of 1.53%.